[在冠心病和急性冠脉综合征中使用ADP受体拮抗剂] - Suppr

Suppr

超能文献

[Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].

作者信息

Schreiber Peter, Fauchère Ivan, Wyss Christophe

机构信息

Klinik für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich.

Klinik für Kardiologie, Universitätsspital Zürich.

出版信息

Praxis (Bern 1994). 2014 Sep 3;103(18):1049-58. doi: 10.1024/1661-8157/a001762.

DOI:10.1024/1661-8157/a001762

PMID:25183612

Abstract

摘要

相似文献

[Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].

Praxis (Bern 1994). 2014 Sep 3;103(18):1049-58. doi: 10.1024/1661-8157/a001762.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Epub 2011 Mar 22.

[Coronary heart disease: news about stents and bypasses].

Dtsch Med Wochenschr. 2013 Jun;138(23):1225-8. doi: 10.1055/s-0033-1343175. Epub 2013 May 29.

Is it appropriate to compare the results from two clinical trials with one drug in common?

Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):151-3. doi: 10.1016/j.rec.2012.06.014. Epub 2012 Sep 14.

Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.

Int J Cardiol. 2013 Oct 12;168(5):5004-5. doi: 10.1016/j.ijcard.2013.07.121. Epub 2013 Jul 31.

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.

Circulation. 2013 Aug 20;128(8):823-33. doi: 10.1161/CIRCULATIONAHA.113.002303. Epub 2013 Jul 12.

New antiplatelet agents in the treatment of acute coronary syndromes.

Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11.

ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.

J Cardiothorac Vasc Anesth. 2013 Aug;27(4):779-95. doi: 10.1053/j.jvca.2012.11.014. Epub 2013 May 3.

Triple therapy: boon or bane for high-risk CV patients?

J Fam Pract. 2011 Apr;60(4):187-92.

Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor.

Circulation. 2011 Feb 1;123(4):451-6. doi: 10.1161/CIRCULATIONAHA.110.985325. Epub 2011 Jan 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].

作者信息

Schreiber Peter, Fauchère Ivan, Wyss Christophe

机构信息

Klinik für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich.

Klinik für Kardiologie, Universitätsspital Zürich.

出版信息

Praxis (Bern 1994). 2014 Sep 3;103(18):1049-58. doi: 10.1024/1661-8157/a001762.

DOI:10.1024/1661-8157/a001762

PMID:25183612

Abstract

摘要

相似文献

[Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].

Praxis (Bern 1994). 2014 Sep 3;103(18):1049-58. doi: 10.1024/1661-8157/a001762.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Epub 2011 Mar 22.

[Coronary heart disease: news about stents and bypasses].

Dtsch Med Wochenschr. 2013 Jun;138(23):1225-8. doi: 10.1055/s-0033-1343175. Epub 2013 May 29.

Is it appropriate to compare the results from two clinical trials with one drug in common?

Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):151-3. doi: 10.1016/j.rec.2012.06.014. Epub 2012 Sep 14.

Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.

Int J Cardiol. 2013 Oct 12;168(5):5004-5. doi: 10.1016/j.ijcard.2013.07.121. Epub 2013 Jul 31.

Circulation. 2013 Aug 20;128(8):823-33. doi: 10.1161/CIRCULATIONAHA.113.002303. Epub 2013 Jul 12.

New antiplatelet agents in the treatment of acute coronary syndromes.

Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11.

ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.

J Cardiothorac Vasc Anesth. 2013 Aug;27(4):779-95. doi: 10.1053/j.jvca.2012.11.014. Epub 2013 May 3.

Triple therapy: boon or bane for high-risk CV patients?

J Fam Pract. 2011 Apr;60(4):187-92.

Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor.

Circulation. 2011 Feb 1;123(4):451-6. doi: 10.1161/CIRCULATIONAHA.110.985325. Epub 2011 Jan 17.